| |
| |
Welcome to our final newsletter of 2022. We have plenty to update you on about our work over the last couple of months, but I also want to take the opportunity to reflect on such a productive year and thank all our partners who have helped us in delivering our purpose to turn great ideas into positive impact.
Piers Ricketts
Chief Executive, Eastern AHSN
| |
| |
| |
Pilot to screen for lung cancer in primary care
Read how our pilot of Oncimmune’s EarlyCDT Lung test identified seven previously undiagnosed early-stage primary cancers among the 1,919 patients who took part. The pilot was delivered with the East of England Cancer Alliance and Norfolk and Waveney ICS to explore the use of a blood test to support earlier lung cancer detection. The findings suggested an increase in quality-adjusted life years for those diagnosed through the test. Read more and download the full evaluation in this impact story.
| |
| |
Real-world validation report
The AHSN Network has published a guide to address one of the fundamental challenges faced by the NHS, industry, and innovators in the UK – the ability for the health and social care system to adopt well-evidenced transformational HealthTech innovations at sufficient pace and scale. It aims to help innovators think clearly about what they want from any real-world evaluation through practical tips and case studies.
| |
| |
| |
| |
Focus ADHD programme wins mental health innovation award
The Focus ADHD Programme, being delivered by the AHSN Network and QbTech, has won the Innovative Mental Health Intervention category at the National Mental Health and Wellbeing awards.
In the East of England, we have rolled this programme out across four health systems, supporting changes in pathways, workforce and data collection. To date 418 QbTech tests have been completed to support the clinical assessment of ADHD.
| |
| |
| |
Understanding people’s views on urgent and emergency care
NHS England commissioned Eastern AHSN to understand citizens’ experiences of urgent and emergency care services in England and how digital technology and innovation might improve services. NHS England has released the first in a two-part podcast series which introduces the research and shares details on the mixed method approach used.
| |
| |
Separate research databases successfully federated in what is believed to be a UK first | | |
| |
Researchers can securely work with multiple remote healthcare databases without any source data needing to be moved because of work by a team comprising local healthcare and research organisations in Cambridge, including Eastern AHSN.
The DARE UK Federated Genomics project, led by the University of Cambridge, has successfully achieved what we believe to be the UK’s first demonstration of genomic data federation by bridging the Trusted Research Environments (TRE) of NIHR BioResource and Genomics England to enable researchers to safely access and work with both databases without moving any original data. | | |
| |
| |
Carbon literacy training launched for innovators The NHS aims to reduce its greenhouse gas emissions to net zero within its supply chain by 2045. This has implications for those who want to become suppliers or partners to the NHS now and in the future. Eastern AHSN and Carbon Action have launched accredited ISO training programmes to improve carbon literacy in healthcare. | |
| |
| |
Eastern AHSN relaunches Stroke Forum Eastern AHSN will host the East of England Stroke Forum until July 2025. The aim of the Forum is to nurture, develop and sustain a community of knowledgeable professionals competent in meeting the needs of individuals affected by stroke in the East of England. Our role within the Forum also ties in with our work to help address the identification and prevention of conditions linked with cardiovascular disease (CVD) across the East of England. | |
| |
| |
| |
Lumi Nova included in list of treatments conditional recommended by NICE to treat anxiety Lumi Nova, the digital therapeutic tool created by local innovators at BfB Labs, has been conditionally recommended by NICE as a front-line treatment option to treat anxiety and low mood in children and young people. We are working with the team to pilot the use of Lumi Nova in Norfolk to evaluate the clinical benefit in children and how it might help address inequalities in healthcare, as research shows that children from disadvantaged, marginalised, or ethnic minority communities are more likely to experience anxiety disorders but are the least likely to access mental health services. | |
| |
| |
Understanding familial hypercholesterolaemia: Mark's story | |
We spoke to Mark, who was diagnosed with familial hypercholesterolaemia (FH) in 2018 after being tested because his mother was found to have the condition. Please listen to his story. We are supporting the rollout of child-parent screening with the AHSN Network to identify FH as part of our drive to improve the prevention, diagnosis and treatment of cardiovascular disease.
| |
| |
| |
| |
Transforming Wound Care pilot sites announced Transforming Wound Care is a new national programme to improve care for patients with lower limb wounds. We’re delighted to announce a pilot site in our region to establish local dedicated lower limb wound services within NHS Norfolk and Waveney Integrated Care Board (ICB) services. | |
| |
| |
How can digital technology alleviate current pressures on the front line of primary care? Piers Ricketts recently jointly hosted a discussion which set out to address how digital technology could alleviate the pressures on the frontline in general practice. He was joined by colleagues from the Royal College of General Practitioners, the London Borough of Tower Hamlets, Cambridgeshire and Peterborough ICS, and leaders from two technology companies. You can read his reflections on the session in this blog co-authored by Lord James O’Shaughnessy. | |
| |
Cambridgeshire and Peterborough Adopting Innovation Hub Showcase Event Apply now for the opportunity to share your innovation's impact with senior leaders, innovators, front-line early adopters, staff and patients from across Cambridgeshire and Peterborough at the Adopting Innovation Hub’s event in summer 2023. | |
| |
| |
Clinical Innovators Forum 6 December 2022 (online)Run in partnership with Health Tech Enterprise, this is a great place to network and hear speakers share their first-hand experience and explain the support available to enable NHS innovators to translate their idea from a concept to a fully marketable medical product or service ready to take on the world. | |
| |
| |
Novel Injectable Therapies Across the Lipid Management Pathway 14 December 2022, 6.30pm (online)This webinar will discuss innovative therapies, their place in combination lipid-lowering therapy as the first line strategy in very high-risk patients and show how much they can support the NHS Long Term Plan ambitions of reducing cardiovascular disease through Population Health Management. | |
| |
| |
The Early Intervention for Eating Disorders Programme has been embedded across four ICSs in the East of England, with over 150 young people in our region having received NICE-recommended treatment for eating disorders as a result of this work to date.
| | | |
| |
| |
Thank you for supporting us as we continue to turn great ideas into positive health impact.
| |
| |
| |
Our mailing address is: Unit C, Magog Court, Shelford Bottom, Cambridge,CB22 3AD You can read the Eastern AHSN privacy policy here. | |
| |
